KYN
Kyntra Bio, Inc. Common Stock
KYNB • NASDAQ
Kyntra Bio, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Thane Wettig, with a market cap of $29.1M.
Market Cap$29.1M
CEOThane Wettig
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
KYN
Kyntra Bio, Inc. Common Stock FAQ
Common questions about Kyntra Bio, Inc. Common Stock
Kyntra Bio, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $1.6M.